Development and Validation of a S1 Protein-Based ELISA for the Specific Detection of Antibodies against Equine Coronavirus.
Abstract: Equine coronavirus (ECoV) is considered to be involved in enteric diseases in foals. Recently, several outbreaks of ECoV infection have also been reported in adult horses from the USA, France and Japan. Epidemiological studies of ECoV infection are still limited, and the seroprevalence of ECoV infection in Europe is unknown. In this study, an indirect enzyme-linked immunosorbent assay (ELISA) method utilizing ECoV spike S1 protein was developed in two formats, and further validated by analyzing 27 paired serum samples (acute and convalescent sera) from horses involved in an ECoV outbreak and 1084 sera of horses with unknown ECoV exposure. Both formats showed high diagnostic accuracy compared to virus neutralization (VN) assay. Receiver-operating characteristic (ROC) analyses were performed to determine the best cut-off values for both ELISA formats, assuming a test specificity of 99%. Employing the developed ELISA method, we detected seroconversion in 70.4% of horses from an ECoV outbreak. Among the 1084 horse sera, seropositivity varied from 25.9% (young horses) to 82.8% (adult horses) in Dutch horse populations. Further, sera of Icelandic horses were included in this study and a significant number of sera (62%) were found to be positive. Overall, the results demonstrated that the ECoV S1-based ELISA has reliable diagnostic performance compared to the VN assay and is a useful assay to support seroconversion in horses involved with ECoV outbreaks and to estimate ECoV seroprevalence in populations of horses.
Publication Date: 2019-11-30 PubMed ID: 31801275PubMed Central: PMC6950238DOI: 10.3390/v11121109Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Validation Study
- Adult Horses
- Antibodies
- Clinical Study
- Comparative Study
- Diagnostic Technique
- Disease
- Disease Outbreaks
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Epidemiology
- Equine Coronavirus
- Equine Health
- Equine Science
- Icelandic Horses
- Immunology
- Infection
- Serological Surveys
- Seroprevalence
- Veterinary Medicine
- Veterinary Research
- Young Horses
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article revolves around the development and validation of a detection method for antibodies against Equine Coronavirus (ECoV) in horses using an enzyme-linked immunosorbent assay (ELISA) technique, specifically with the ECoV spike S1 protein. The method was deemed to have a reliable diagnostic performance compared to traditional methods and could be used to estimate ECoV occurrence in horse populations.
Development of the ELISA Method
- The research team developed an indirect ELISA method that uses ECoV spike S1 protein. This method involved testing serum samples from horses for antibodies against ECoV.
- The method was developed in two formats to compare the diagnostic accuracy and validate its effectiveness. The performance of these two formats was then compared with the virus neutralization (VN) assay, a traditional method of diagnosing virally infected samples.
- After conducting receiver-operating characteristic (ROC) analyses on both ELISA formats, best cut-off values were determined for each, assuming a test specificity of 99%.
Validation of the ELISA Method
- The ELISA method was validated by analyzing 27 paired serum samples (acute and convalescent sera) from horses involved in an ECoV outbreak and 1084 sera of horses with unknown ECoV exposure.
- 70.4% of horses from an ECoV outbreak showed seroconversion (the period of time during an infection when antibodies start to become detectable) when tested with the developed ELISA method.
Estimating ECoV Seroprevalence in Horse Populations
- The research also used this ELISA method to estimate the seroprevalence (the level of a pathogen in a population as measured in blood serum) of ECoV in various horse populations.
- Among 1084 tested horse sera, seropositivity rates varied between 25.9% (for young horses) and 82.8% (for adult horses) in Dutch horse populations.
- Serum samples from Icelandic horses were also tested, and a significant number (62%) were found to be positive.
Conclusion
- The findings of the study demonstrate that the ECoV S1 protein-based ELISA method has reliable diagnostic performance compared to the traditional VN assay.
- The study concludes that this ELISA method could be a useful tool for confirming seroconversion in horses involved in ECoV outbreaks, and for estimating the seroprevalence of ECoV in horse populations.
Cite This Article
APA
Zhao S, Smits C, Schuurman N, Barnum S, Pusterla N, Kuppeveld FV, Bosch BJ, Maanen KV, Egberink H.
(2019).
Development and Validation of a S1 Protein-Based ELISA for the Specific Detection of Antibodies against Equine Coronavirus.
Viruses, 11(12).
https://doi.org/10.3390/v11121109 Publication
Researcher Affiliations
- Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, The Netherlands.
- GD Animal Health, Department of Small Ruminants, Horses and Companion Animals, Arnsbergstraat 7, 7418EZ Deventer, The Netherlands.
- Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, The Netherlands.
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, One Shields Ave., Davis, CA 95616, USA.
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, One Shields Ave., Davis, CA 95616, USA.
- Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, The Netherlands.
- Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, The Netherlands.
- GD Animal Health, Department of Small Ruminants, Horses and Companion Animals, Arnsbergstraat 7, 7418EZ Deventer, The Netherlands.
- Virology Division, Department of Infectious Diseases & Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584CL Utrecht, The Netherlands.
MeSH Terms
- Animals
- Antibodies, Neutralizing / blood
- Antibodies, Viral / blood
- Betacoronavirus 1 / immunology
- Betacoronavirus 1 / isolation & purification
- Coronavirus Infections / diagnosis
- Coronavirus Infections / epidemiology
- Coronavirus Infections / veterinary
- Enzyme-Linked Immunosorbent Assay / veterinary
- Horse Diseases / diagnosis
- Horse Diseases / epidemiology
- Horses
- Iceland / epidemiology
- Netherlands / epidemiology
- ROC Curve
- Seroepidemiologic Studies
- Serologic Tests / methods
- Serologic Tests / veterinary
- Spike Glycoprotein, Coronavirus / immunology
Conflict of Interest Statement
The authors declare no conflict of interest.
References
This article includes 40 references
- Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses.. Nat. Rev. Microbiol. 2019;17:181–192.
- Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses.. Trends Microbiol. 2016;24:490–502.
- Zhang J, Guy JS, Snijder EJ, Denniston DA, Timoney PJ, Balasuriya UBR. Genomic characterization of equine coronavirus.. Virology. 2007;369:92–104.
- Guy JS, Breslin JJ, Breuhaus B, Vivrette S, Smith LG. Characterization of a coronavirus isolated from a diarrheic foal.. J. Clin. Microbiol. 2000;38:4523–4526.
- Oue Y, Ishihara R, Edamatsu H, Morita Y, Yoshida M, Yoshima M, Hatama S, Murakami K, Kanno T. Isolation of an equine coronavirus from adult horses with pyrogenic and enteric disease and its antigenic and genomic characterization in comparison with the NC99 strain.. Vet. Microbiol. 2011;150:41–48.
- Miszczak F, Tesson V, Kin N, Dina J, Balasuriya UBR, Pronost S, Vabret A. First detection of equine coronavirus (ECoV) in Europe.. Vet. Microbiol. 2014;171:206–209.
- Pusterla N, Mapes S, Wademan C, White A, Ball R, Sapp K, Burns P, Ormond C, Butterworth K, Bartol J. Emerging outbreaks associated with equine coronavirus in adult horses.. Vet. Microbiol. 2013;162:228–231.
- Oue Y, Morita Y, Kondo T, Nemoto M. Epidemic of equine coronavirus at obihiro racecourse, Hokkaido, Japan in 2012.. J. Vet. Med. Sci. 2013;75:1261–1265.
- Nemoto M, Schofield W, Cullinane A. The First Detection of Equine Coronavirus in Adult Horses and Foals in Ireland.. Viruses. 2019;11:946.
- Pusterla N, Vin R, Leutenegger CM, Mittel LD, Divers TJ. Enteric coronavirus infection in adult horses.. Vet. J. 2018;231:13–18.
- Pusterla N, James K, Mapes S, Bain F. Frequency of molecular detection of equine coronavirus in faeces and nasal secretions in 277 horses with acute onset of fever.. Vet. Rec. 2019;184:385.
- Fielding CL, Higgins JK, Higgins JC, Mcintosh S, Scott E, Giannitti F, Mete A, Pusterla N. Disease Associated with Equine Coronavirus Infection and High Case Fatality Rate.. J. Vet. Intern. Med. 2015;29:307–310.
- Berryhill EH, Magdesia KG, Aleman M, Pusterla N. Clinical presentation, diagnostic findings, and outcome of adult horses with equine coronavirus infection at a veterinary teaching hospital: 33 cases (2012–2018). Vet. J. 2019;248:95–100.
- Sanz MG, Kwon SY, Pusterla N, Gold JR, Bain F, Evermann J. Evaluation of equine coronavirus fecal shedding among hospitalized horses.. J. Vet. Intern. Med. 2019;33:918–922.
- Nemoto M, Oue Y, Morita Y, Kanno T, Kinoshita Y, Niwa H, Ueno T, Katayama Y, Bannai H, Tsujimura K. Experimental inoculation of equine coronavirus into Japanese draft horses.. Arch. Virol. 2014;159:3329–3334.
- Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013.. Eurosurveillance. 2013;18:20574.
- Payne DC, Iblan I, Rha B, Alqasrawi S, Haddadin A, Al Nsour M, Alsanouri T, Ali SS, Harcourt J, Miao C. Persistence of antibodies against middle east respiratory syndrome coronavirus.. Emerg. Infect. Dis. 2016;22:1824–1826.
- Tråvén M, Näslund K, Linde N, Linde B, Silván A, Fossum C, Hedlund KO, Larsson B. Experimental reproduction of winter dysentery in lactating cows using BCV—Comparison with BCV infection in milk-fed calves.. Vet. Microbiol. 2001;81:127–151.
- Dortmans JCFM, Li W, van der Wolf PJ, Buter GJ, Franssen PJM, van Schaik G, Houben M, Bosch BJ. Porcine epidemic diarrhea virus (PEDV) introduction into a naive Dutch pig population in 2014.. Vet. Microbiol. 2018;221:13–18.
- Reusken CBEM, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B, Muth D, Raj VS, De Vries LS, Corman VM. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: A comparative serological study.. Lancet Infect. Dis. 2013;13:859–866.
- Leung GM, Chung PH, Tsang T, Lim W, Chan SKK, Chau P, Donnelly CA, Ghani AC, Fraser C, Riley S. SARS-CoV antibody prevalence in all Hong Kong patient contacts.. Emerg. Infect. Dis. 2004;10:1653–1656.
- Walls AC, Tortorici MA, Bosch BJ, Frenz B, Rottier PJM, DiMaio F, Rey FA, Veesler D. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer.. Nature. 2016;531:114–117.
- Hulswit RJG, de Haan CAM, Bosch BJ. Coronavirus Spike Protein and Tropism Changes. Advances in virus research. Volume 96. Elsevier; Amsterdam, The Netherlands 2016;pp. 29–57.
- Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein.. Viruses. 2012;4:1011–1033.
- Meyer B, Drosten C, Müller MA. Serological assays for emerging coronaviruses: Challenges and pitfalls.. Virus Res. 2014;194:175–183.
- Zhao S, Li W, Schuurman N, van Kuppeveld F, Bosch BJ, Egberink H. Serological Screening for Coronavirus Infections in Cats.. Viruses. 2019;11:743.
- Kooijman LJ, Mapes SM, Pusterla N. Development of an equine coronavirus-specific enzyme-linked immunosorbent assay to determine serologic responses in naturally infected horses.. J. Vet. Diagn. Invest. 2016;28:414–418.
- Bryan J, Marr CM, Mackenzie CJ, Mair TS, Fletcher A, Cash R, Phillips M, Pusterla N, Mapes S, Foote AK. Detection of equine coronavirus in horses in the United Kingdom.. Vet. Rec. 2019;184:123.
- Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells.. Nat. Biotechnol. 2004;22:1393–1398.
- Reusken C, Mou H, Godeke G, van der Hoek L, Meyer B, Müller M, Haagmans B, de Sousa R, Schuurman N, Dittmer U. Specific serology for emerging human coronaviruses by protein microarray.. Eurosurveillance. 2013;18:20441.
- Okba NMA, Raj VS, Widjaja I, GeurtsvanKessel CH, de Bruin E, Chandler FD, Park WB, Kim NJ, Farag EABA, Al-Hajri M. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.. Emerg. Infect. Dis. 2019;25:1868–1877.
- Hemida MG, Chu DKW, Perera RAPM, Ko RLW, So RTY, Ng BCY, Chan SMS, Chu S, Alnaeem AA, Alhammadi MA. Coronavirus infections in horses in Saudi Arabia and Oman.. Transbound. Emerg. Dis. 2017;64:2093–2103.
- Kooijman LJ, James K, Mapes SM, Theelen MJP, Pusterla N. Seroprevalence and risk factors for infection with equine coronavirus in healthy horses in the USA.. Vet. J. 2017;220:91–94.
- He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, Jiang S. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: Implication for developing SARS diagnostics and vaccines.. J. Immunol. 2004;173:4050–4057.
- He Y, Li J, Heck S, Lustigman S, Jiang S. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: Implication for vaccine design.. J. Virol. 2006;80:5757–5767.
- Bass EP, Sharpee RL. Coronavirus and gastroenteritis in foals.. Lancet (London, England) 1975;2:822.
- Durham PJK, Stevenson BJ, Farquharson BC. Rotavirus and coronavirus associated diarrhoea in domestic animals.. N. Z. Vet. J. 1979;27:30–32.
- Huang JC, Wright SL, Shipley WD. Isolation of coronavirus-like agent from horses suffering from acute equine diarrhoea syndrome.. Vet. Rec. 1983;113:262–263.
- Mair TS, Taylor FG, Harbour DA, Pearson GR. Concurrent cryptosporidium and coronavirus infections in an Arabian foal with combined immunodeficiency syndrome.. Vet. Rec. 1990;126:127–130.
- Björnsdóttir S, Harris SR, Svansson V, Gunnarsson E, Sigurðardóttir ÓG, Gammeljord K, Steward KF, Newton JR, Robinson C, Charbonneau ARL. Genomic Dissection of an Icelandic Epidemic of Respiratory Disease in Horses and Associated Zoonotic Cases.. MBio. 2017;8.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists